ZYUS Life Sciences’ (ZYU) “Buy” Rating Reiterated at Roth Capital
Roth Capital reiterated their buy rating on shares of ZYUS Life Sciences (CVE:ZYU – Free Report) in a report published on Thursday, PriceTargets.com reports. Separately, Stifel Canada reissued a speculative buy rating on shares of ZYUS Life Sciences in a research note on Friday, January 26th. Check Out Our Latest Research Report on ZYUS Life […]
More Stories
White House’s Muddled Responses Added Fuel to the Fire in Alex Pretti’s Shooting in Minneapolis
Chaos spread around the White House like wildfire in the tense hours after Border Patrol agents fatally shot Alex Pretti,...
Top 12 Video Editing Tools That are Worth Using for US YouTubers
Think about this, you are a YouTuber, and you have uploaded a video, and in hours your video is going...
November US Trade Deficit Widens 94 Percent After Reaching 16-Year Low
By Andrew Moran The U.S. trade deficit in goods and services widened by the most since 1992, one month after...
AG Paxton Announces Investigation Into H-1B Visa Abuse
By Naveen Athrappully Texas Attorney General Ken Paxton is probing the abuse of the H-1B visa program in the state,...
Trump Shares Video Showing Earlier Violent Confrontation Between Pretti and Federal Agents
By Tom Ozimek President Donald Trump on Jan. 28 shared newly released video footage showing Alex Pretti in a violent...
Who is Angela Marmol? Height, Age, and News with Tom Cruise
A social media influencer, Angela, rose to fame through social media platforms like TikTok and Instagram. She is known for...